Sponsor

Glaxo Wellcome

Clinical research sponsor

Published trials119
Recruiting shown0
Roles2
SourceClinicalTrials.gov

Clinical trials

60 shown
Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral TherapyNCT00008554 · lead sponsor · 2000-11-01
UNKNOWN
Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral DrugsNCT00009061 · lead sponsor · 2000-11-01
UNKNOWN
A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive PatientsNCT00005764 · lead sponsor · 2000-05-01
COMPLETED
A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected AdultsNCT00004585 · lead sponsor · 1999-10-01
COMPLETED
Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV DrugsNCT00004852 · lead sponsor · 1999-09-01
COMPLETED
A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected PatientsNCT00005106 · lead sponsor · 1999-09-01
COMPLETED
Safety and Effectiveness of a Combination Anti-HIV Drug TreatmentNCT00005018 · lead sponsor · 1999-07-01
COMPLETED
A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected PatientsNCT00005663 · lead sponsor · 1999-06-01
UNKNOWN
A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV DrugsNCT00002442 · lead sponsor · 1999-06-01
COMPLETED
A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected PatientsNCT00002245 · lead sponsor · 1999-04-01
COMPLETED
A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include AmprenavirNCT00002423 · lead sponsor · 1999-03-01
COMPLETED
The Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected PatientsNCT00002404 · lead sponsor
COMPLETED
A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the PastNCT00002320 · lead sponsor
COMPLETED
An Oral Dose-Ranging Finding Study in Patients With HIV Disease, CDC Classification Groups IIB, III, and IV-C2NCT00002023 · lead sponsor
COMPLETED
The Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous SystemNCT00002288 · lead sponsor
COMPLETED
A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMXNCT00002340 · lead sponsor
COMPLETED
Trial of an Alternative Dosing Regimen of Oral Retrovir in Patients With AIDS or Advanced ARCNCT00002020 · lead sponsor
COMPLETED
A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)NCT00002014 · lead sponsor
COMPLETED
An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral PentamidineNCT00001990 · lead sponsor
COMPLETED
The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease InhibitorsNCT00002213 · lead sponsor
COMPLETED
A Study of Amprenavir in Patients With Protease Inhibitor-Related ComplicationsNCT00002417 · lead sponsor
COMPLETED
A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected PatientsNCT00002195 · lead sponsor
COMPLETED
A Study of 1592U89 in HIV-Infected AdultsNCT00002200 · lead sponsor
COMPLETED
Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)NCT00002026 · lead sponsor
COMPLETED
The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZTNCT00002436 · lead sponsor
COMPLETED
A Dose-Frequency Trial of Oral Retrovir in Patients With AIDS or Severe ARCNCT00002046 · lead sponsor
COMPLETED
3TC (Lamivudine; GR109714X) Open-Label ProgramNCT00002108 · lead sponsor
COMPLETED
A Study of 141W94 in Combination With Other Anti-HIV DrugsNCT00002372 · lead sponsor
COMPLETED
A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV TreatmentNCT00002216 · lead sponsor
COMPLETED
A Study of 1592U89 and Ethanol When Given Together to HIV-Infected PatientsNCT00002198 · lead sponsor
COMPLETED
A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected PatientsNCT00002084 · lead sponsor
COMPLETED
The Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected PatientsNCT00002373 · lead sponsor
COMPLETED
A Study of a Combination of Four Drugs in Patients With Recent HIV InfectionNCT00002233 · lead sponsor
COMPLETED
Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)NCT00004981 · lead sponsor
UNKNOWN
The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 DrugsNCT00002391 · lead sponsor
COMPLETED
A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia ComplexNCT00002163 · lead sponsor
COMPLETED
The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus DiseaseNCT00002001 · lead sponsor
COMPLETED
A Randomized Trial to Evaluate the Safety and Efficacy of Combination Therapy With Retrovir ( AZT ) and HIVID ( ddC ) Versus Retrovir, HIVID, and Wellferon ( Interferon Alfa-n1 ) for the Treatment of HIV InfectionNCT00002086 · lead sponsor
COMPLETED
A Study of Zidovudine and T Lymphocyte Transfer in the Treatment of HIV Type III in Patients With AIDSNCT00002285 · lead sponsor
COMPLETED
A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-SulfadiazineNCT00001994 · lead sponsor
COMPLETED
The Safety and Effectiveness of 524W91NCT00002335 · lead sponsor
COMPLETED
A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular DiseasesNCT00002044 · lead sponsor
COMPLETED
A Study of Azidothymidine (AZT) in the Treatment of HIV Infection in Patients Receiving a Bone Marrow TransplantNCT00002284 · lead sponsor
COMPLETED
A Study of 1592U89 in HIV-Infected ChildrenNCT00002197 · lead sponsor
COMPLETED
The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)NCT00002048 · lead sponsor
COMPLETED
A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune SystemsNCT00002315 · lead sponsor
COMPLETED
A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV DrugsNCT00002440 · lead sponsor
COMPLETED
Treatment of AIDS and AIDS Related Complex. Part-1- Treatment of Patients With ARC (AZT Vs. Placebo)NCT00002063 · lead sponsor
COMPLETED
A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.NCT00002199 · lead sponsor
COMPLETED
A Treatment IND for 566C80 Therapy of Pneumocystis Carinii PneumoniaNCT00001991 · lead sponsor
COMPLETED
A Study of Amprenavir in HIV-Infected PatientsNCT00002405 · lead sponsor
COMPLETED
The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV DrugsNCT00002389 · lead sponsor
COMPLETED
A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV DrugsNCT00002217 · lead sponsor
COMPLETED
A Prospective Double-Blind Study of Retrovir in Early HIV InfectionNCT00002045 · lead sponsor
COMPLETED
The Safety and Effectiveness of Zidovudine Plus Acyclovir in Patients With Early HIV InfectionNCT00002290 · lead sponsor
COMPLETED
Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received TreatmentNCT00005017 · lead sponsor
UNKNOWN
A Study of 1592U89 in HIV-Infected PatientsNCT00002388 · lead sponsor
COMPLETED
The Safety and Effectiveness of 935U83 in HIV-Infected PatientsNCT00002338 · lead sponsor
COMPLETED
A Study of Two Anti-HIV Drug CombinationsNCT00002203 · lead sponsor
COMPLETED
An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment RegimenNCT00002205 · lead sponsor
COMPLETED

Sponsor roles

lead sponsor72
collaborator47

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.